Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

21 Jul 2014 07:00

RNS Number : 7841M
Standard Life Euro Pri Eqty Tst PLC
21 July 2014
 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 30 June 2014

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 April 2014 to 30 June 2014. This announcement constitutes the Company's second interim management statement for the financial year ending 30 September 2014 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information at 30 June 2014 and any material developments up to 18 July 2014.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's net asset value per ordinary share ("NAV") was 252.2p and its net assets were £401.2 million at 31 March 2014. The Company's NAV at 30 June 2014 will be announced on or around 23 September 2014. The share price of the Company's ordinary shares was 215.0p at 30 June 2014, compared to 204.0p at 31 March 2014, an increase of 5.4% over the quarter.

 

Over the same quarter the MSCI Europe Index (in euros) rose by 2.6% and the FTSE All Share Index (in sterling) rose by 1.3%.

 

Financial position

 

During the quarter ended 30 June 2014 the Company funded £15.3 million of draw downs (six months ended 31 March 2014 - £15.9 million) and received £13.0 million of distributions (six months ended 31 March 2014 - £49.3 million). Draw down activity increased during the quarter as a result of new investment activity by a number of recent fund commitments, notably Permira V where draw downs totalled £5.2 million. While it was a quieter quarter for distributions, the Manager is aware of a number of exits having occurred where the Company is awaiting cash proceeds. As a result of the above, draw downs and distributions for the nine months ended 30 June 2014 were £31.2 million and £62.3 million, respectively.

 

The Company made no new fund commitments in the quarter ended 30 June 2014. The Company had total outstanding commitments to its 42 private equity fund interests of £192.0 million at 30 June 2014 (31 March 2014 - £213.5 million). The Manager continues to believe that up to £40 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2014 the Company had a cash balance, including holdings in money market funds, of £18.1 million and had £22.0 million invested in UK and European equity index tracker funds (31 March 2014 - £22.7 million and £21.9 million, respectively). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

 

Directorate changes

 

On 28 May 2014 the Company announced the appointment of Alan Devine to the Board as a non-executive director.

 

Alternative Investment Fund Managers Directive ("AIFMD" or "the Directive")

 

The Company is required to comply with the European Union AIFMD. The Directive requires the Company to appoint an Alternative Investment Fund Manager ("AIFM") who will be responsible for portfolio and risk management and will be regulated under the Directive. The Board has agreed to appoint SL Capital Partners LLP as the AIFM. The Directive also requires the Company to appoint a depositary and the Board has appointed BNP Paribas Securities Services to fulfil this function.

 

Events and transactions in the period to 18 July 2014

 

During the period from 30 June 2014 to 18 July 2014 the Company funded £5.4 million of draw downs and received £15.0 million of distributions. At 18 July 2014 the Company had a cash balance, including holdings in money market funds, of £26.2 million and had £21.6 million invested in UK and European equity index tracker funds.

 

The Company has also made a new commitment of €55.0 million to Altor IV, a Nordic mid-market buy-out fund.Accordingly, at 18 July 2014 the Company had outstanding commitments of £227.9 million.

 

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the London Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDRGDBBGSI
Date   Source Headline
8th Oct 20185:07 pmRNSDirector/PDMR Shareholding
2nd Oct 20181:04 pmRNSQuarterly Disclosure
1st Oct 20187:00 amRNSEstimated Net Asset Value at 31 August 2018
1st Oct 20187:00 amRNSQuarterly Trading Statement
7th Sep 20187:00 amRNSDividend Declaration
30th Aug 20182:24 pmRNSDirector/PDMR Shareholding
28th Aug 20187:00 amRNSChange of Auditor
14th Aug 20187:00 amRNSEstimated Net Asset Value at 31 July 2018
8th Aug 20189:14 amRNSDirector/PDMR Shareholding
3rd Aug 20183:33 pmRNSDirector/PDMR Shareholding
17th Jul 201812:17 pmRNSUpdate research from QuotedData
13th Jul 20183:22 pmRNSEdison reviews Standard Life Private Equity Trust
13th Jul 20187:00 amRNSEstimated Net Asset Value at 30 June 2018
11th Jul 20185:32 pmRNSHolding(s) in Company
5th Jul 201811:55 amRNSDirector/PDMR Shareholding
3rd Jul 201812:43 pmRNSQuarterly Disclosure
18th Jun 20187:02 amRNSEstimated Net Asset Value at 31 May 2018
18th Jun 20187:01 amRNSDividend Declaration
18th Jun 20187:00 amRNSHalf-year Report
15th Jun 201811:50 amRNSDirectorate Change
15th May 20187:00 amRNSEstimated Net Asset Value at 30 April 2018
14th May 20183:48 pmRNSDirector/PDMR Shareholding
8th May 201812:06 pmRNSDirector/PDMR Shareholding
8th May 201812:02 pmRNSDirector/PDMR Shareholding
1st May 201812:54 pmRNSDirector/PDMR Shareholding
18th Apr 20183:24 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSEstimated Net Asset Value at 31 March 2018
4th Apr 20182:09 pmRNSQuarterly Disclosure
26th Mar 20187:00 amRNSEstimated Net Asset Value at 28 February 2018
26th Mar 20187:00 amRNSQuarterly Trading Statement
21st Mar 20187:00 amRNSDividend Declaration
16th Mar 20189:46 amRNSHolding(s) in Company
13th Mar 201810:53 amRNSHolding(s) in Company
8th Mar 201811:00 amRNSKepler Trust Intelligence Research
27th Feb 20185:22 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSEstimated Net Asset Value at 31 January 2018
9th Feb 20183:45 pmRNSDirector/PDMR Shareholding
9th Feb 20183:44 pmRNSDirector/PDMR Shareholding
7th Feb 201811:38 amRNSEdison review: Standard Life Private Equity Trust
2nd Feb 201811:29 amRNSDirector/PDMR Shareholding
31st Jan 20183:17 pmRNSDirector/PDMR Shareholding
25th Jan 20182:48 pmRNSResult of AGM
15th Jan 20187:00 amRNSEstimated Net Asset Value at 31 December 2017
3rd Jan 20182:28 pmRNSQuarterly Disclosure
3rd Jan 201810:52 amRNSDirector/PDMR Shareholding
14th Dec 20177:00 amRNSEstimated Net Asset Value at 30 November 2017
13th Dec 20173:41 pmRNSDirector/PDMR Shareholding
13th Dec 201711:26 amRNSDirector/PDMR Shareholding
11th Dec 20177:00 amRNSDividend Declaration
8th Dec 201711:58 amRNSUpdate research from QuotedData

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.